Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN1896100B Liver regenerated factor and its use
10/13/2010CN1802171B Stable, aqueous solution of human erythropoietin, not containing serum albumin
10/13/2010CN1774281B Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/13/2010CN1737147B Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein (HSP65-HBcAg)
10/13/2010CN101861335A Manufacture, compositions and uses of coagulationfactor VIIA modulator
10/13/2010CN101861334A Cyclic receptor-associated protein (RAP) peptides
10/13/2010CN101861332A Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
10/13/2010CN101861330A Polypeptide compound
10/13/2010CN101861187A Methods and compositions for treating dry eye
10/13/2010CN101861164A Treatment of prion protein related diseases
10/13/2010CN101861162A Method for treating cancer via the mucosal administration of interleukin
10/13/2010CN101861161A Activin-ACTRIIA antagonists and uses for decreasing or inhibiting FSH secretion
10/13/2010CN101861160A Antagonists of kisspeptin and uses thereof
10/13/2010CN101861159A Improved antitumoral treatments
10/13/2010CN101861142A Stabilisation of liquid-formulated factor VII(a) polypeptides by aldehyde-containing compounds
10/13/2010CN101857632A Preparation and use of fatty acyl glycyl glycyl histidine-copper (II) complexes
10/13/2010CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/13/2010CN101856495A Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof
10/13/2010CN101856494A Composition for improving immunity and preparation method thereof
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856363A Application of Bortezomib in preparing drugs for curing POEMS syndrome
10/13/2010CN101856341A Nanometer/micropackaging and releasing of botulinum toxin
10/13/2010CN101856323A Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof
10/13/2010CN101392262B Polypeptide of fungal ubuquitin-conjugating enzyme, coding sequence thereof and preparation method and application
10/13/2010CN101270145B Preparation technique for GHGKHKNK octapeptide and medicine use
10/13/2010CN101240031B Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
10/13/2010CN101235367B Method for preparing ganoderma sinensis streptokinase and application thereof
10/13/2010CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application
10/13/2010CN101143212B Recombination human acidic mechanocyte growth factor temperature sensitive type gel preparation and preparation method thereof
10/13/2010CN101125882B Recombination PAC1 receptor agonist RMMAX and its expression method and application
10/13/2010CN101117630B Preparation method of nattokinase powder and natto Brazil mushroom capsule
10/13/2010CN101070349B Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
10/13/2010CN101054413B Tumor correlated albumen, coding gene and application thereof
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812138 Fractionation of protein containing mixtures
10/12/2010US7812137 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity, diabetes, high blood pressure, and cholesterol
10/12/2010US7812131 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides
10/12/2010US7812130 fusion protein comprising an isolated soluble cytokine receptor polypeptide; use in treatment of cell proliferative, inflammatory and immune disorders
10/12/2010US7812127 Glycosylated with galactose-N-acetylgalactosamine; used for the introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins
10/12/2010US7812125 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/12/2010US7812121 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus
10/12/2010US7812120 Nasal calcitonin formulations containing chlorobutanol
10/12/2010US7812118 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
10/12/2010US7812117 stimulating the proliferation or survival of a hematopoietic cell exposed to a chemotherapeutic agent or irradiation; fusion polypeptide
10/12/2010US7812116 Immunogenic peptides
10/12/2010US7812044 Hormone sensitive vcancer; antiproliferative agents ; induction apoptosis; angiotensin inhibitors
10/12/2010US7812010 Pharmaceutical preparations for treatments of diseases and disorders of the breast
10/12/2010US7812001 RNA aptamers and methods for identifying the same
10/12/2010US7811999 Use of lipid conjugates in the treatment of diseases
10/12/2010US7811995 Therapeutic and diagnostic peptides
10/12/2010US7811994 Phage display selection of anti fungal peptides
10/12/2010US7811993 BRAFV600E-based peptide mutants that induce major histocompatibility complex (MHC) Class I-dependent cytotoxic T cell responses provide prophylactic, diagnosis and therapeutic treatments; anticarcinogenic agents; drug development for non-peptide mimetics and in development of antibodies, vaccines
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure
10/12/2010US7811990 Using tumor necrosis factor modulators/inhibitors as tool in treatment and prevention of spinal cord injury
10/12/2010US7811989 Peptide YY analogs
10/12/2010US7811987 Treating diabetic nephropathy by administering an aromatic-cationic peptide having at least one net positive charge, a minimum of four amino acids, a maximum of about twenty amino acids; example, where aromatic-cationic peptide comprises Phe-D-Arg-Phe-Lys-NH2; antidiabetic agents; gene overexpression
10/12/2010US7811986 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811984 BV8 nucleic acids and polypeptides with mitogenic activity
10/12/2010US7811983 Increased T-cell tumor infiltration and eradication of metastases by mutant light
10/12/2010US7811982 Compounds and methods for treating cancer
10/12/2010US7811981 Methods of and compositions for inhibiting the proliferation of mammalian cells
10/12/2010US7811832 Administering an apoptosis inhibitor to a mammal having an eye with retinal detachment
10/12/2010US7811822 Modulation of neural stem cells and neural progenitor cells
10/12/2010US7811820 Generation, maintenance vascular system tissue; controlling gene expression; cardiovascular disorders
10/12/2010US7811793 Using trangenic escherichia to generate bone morphogenic protein for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents
10/12/2010US7811608 osteogenic composition prepared by subjecting demineralized bone to extraction medium, separating insoluble and soluble extraction products, drying (lyophilization) soluble extract removing moisture, then combining with demineralized bone particles; thickeners; bone morphongenic proteins; free of heating
10/12/2010US7811598 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells
10/12/2010US7811592 For immunizing an animal
10/12/2010US7811587 Botulinum toxin therapy for neuropsychiatric disorders
10/12/2010US7811586 Methods for alleviating testicular pain
10/12/2010US7811581 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy
10/12/2010US7811578 Soluble chimeric peptide inhibitors of HIV entry comprising an IZ trimeric coiled-coil peptide and HIV gp41 N-helix coiled-coil peptide
10/12/2010US7811577 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
10/12/2010US7811575 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010US7811561 MCT-1, a human oncogene
10/12/2010US7811560 Compositions and methods for treating collagen-mediated diseases
10/12/2010US7811559 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders
10/12/2010US7811557 treating a human suffering from stroke by administering directly at the site of stroke human CD 34+/-, Lin-cells from umbilical cord blood (UCB) or peripheral blood, separated from other mononuclear cells prior to use
10/12/2010US7811556 polyoxyethylene glycol-allylmethyldiether-maleic acid sodium salt copolymers with fibroblast growth factors; improved conjugation, crosslinking between polymer and protein; formed via hydrolysis, ammonolysis, aminolysis and alcoholysis of anhydride moieties
10/12/2010US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2375224C Human antithrombin variants
10/12/2010CA2374933C Grf-containing lyophilized pharmaceutical compositions
10/12/2010CA2365266C Soybean protein nutraceuticals
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2307065C Modulating robo:ligand interactions
10/12/2010CA2230925C Fusion protein delivery system and uses thereof
10/12/2010CA2229590C Pharmaceutical composition containing inhibitors of interferon- gamma
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 3163